Provided by Tiger Trade Technology Pte. Ltd.

Boundless Bio, Inc.

2.89
+0.08002.85%
Post-market: 2.88-0.0100-0.35%19:30 EDT
Volume:146.03K
Turnover:418.65K
Market Cap:65.74M
PE:-1.01
High:2.91
Open:2.81
Low:2.81
Close:2.81
52wk High:3.16
52wk Low:0.9612
Shares:22.75M
Float Shares:16.09M
Volume Ratio:1.72
T/O Rate:0.91%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.8563
EPS(LYR):-2.6027
ROE:-67.86%
ROA:-32.77%
PB:1.00
PE(LYR):-1.11

Loading ...

Will Strong Q1 Beat and BOLD+1 Acquisitions Shift Henry Schein's (HSIC) Distribution‑Led Narrative?

Simply Wall St.
·
Jun 24

Sector Update: Healthcare Stocks Advance in Afternoon Trading

MT Newswires Live
·
Jun 24

Top Midday Gainers

MT Newswires Live
·
Jun 24

BUZZ-U.S. STOCKS ON THE MOVE-Boundless Bio, Galectin, UniQure

Reuters
·
Jun 23

Boundless Bio to Merge with Serapha Bio, Restructure Operations

TIPRANKS
·
Jun 23

Sector Update: Healthcare Stocks Mixed Pre-Bell Tuesday

MT Newswires Live
·
Jun 23

Boundless Bio, Serapha Bio Sign Merger Deal With $230 Million Private Placement

MT Newswires Live
·
Jun 23

Boundless Bio to merge with Serapha Bio in all-stock deal, shares to trade as AATD

Reuters
·
Jun 23

Boundless Bio - Co and Serapha Bio Announce All-Stock Merger Agreement

THOMSON REUTERS
·
Jun 23

Boundless Bio - Combined Company Cash Expected to Fund Operations Into Second Half of 2029

THOMSON REUTERS
·
Jun 23

Boundless Bio - Deal Unanimously Approved by Both Boards; Expected to Close in Q4 2026

THOMSON REUTERS
·
Jun 23

Boundless Bio - Combined Company to Operate as Serapha Bio and Trade on Nasdaq as 'Aatd'

THOMSON REUTERS
·
Jun 23

Boundless Bio: Pre-Merger Boundless Bio Stockholders Expected to Own 3.7% of, Pre-Merger Serapha Stockholders Expected to Own 96.3% of Combined Co

THOMSON REUTERS
·
Jun 23

Press Release: Boundless Bio and Serapha Bio Announce Merger Agreement and $230 Million Concurrent Private Placement

Dow Jones
·
Jun 23

NASDAQ TRADE HALT HALT NEWS PENDING AT 07:25 AM

Reuters
·
Jun 23

Boundless Bio Shareholders Back Directors and Auditor Appointments

TIPRANKS
·
Jun 17

Boundless Bio shareholders elect Class II directors at annual meeting

Reuters
·
Jun 17

Boundless Bio Halts Early Cancer Trial, Resetting Expectations for BOLD

TIPRANKS
·
Jun 09

Boundless Bio publishes corporate presentation on ecDNA-directed cancer therapies

Reuters
·
May 09

Boundless Bio Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 08